HCD Wound HealHydrocolloid Dressings for Oculofacial Wound Healing
Hydrocolloid Wound Dressing
Supportive Care Study
Summary
Study start date: February 28, 2025
Actual date on which the first participant was enrolled.This clinical trial is investigating if a special type of dressing called a hydrocolloid dressing, specifically DuoDERM EXTRA THIN, can be a better option for patients undergoing oculofacial plastic and reconstructive surgery. These surgeries involve the area around the eyes and face, which can be sensitive and require careful healing. Normally, after such surgeries, patients need to apply antibiotic ointment, which can be time-consuming and inconvenient. This study seeks to find out if using this dressing can replace the ointment and simplify post-operative care, making recovery easier for patients. In this study, participants will have the hydrocolloid dressing applied immediately after their surgery. The dressing will stay in place until their follow-up appointment one week later, at which point it will be removed. Researchers will evaluate how well the dressing works in terms of healing and whether it effectively reduces the need for additional care like applying ointments. This approach aims to lessen the burden of post-surgery care and improve overall patient experience by potentially offering a simpler and effective wound care solution.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.20 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 100 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location